A Randomized Prospective Trail of HIPEC in Recurrent Ovarian Cancer Patients With HRR Mutation

Clinical trial NCT04473339 · UNKNOWN

Trial details

NCT number: NCT04473339
Sponsor: CAI Hongbing
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Ovarian Cancer Epithelial Ovarian Cancer Ovarian Cancer, Epithelial Hyperthermic Intraperitoneal Chemotherapy(HIPEC)Homologous Recombination Repair Gene Mutation

Start date: 2020-08-01
Primary completion: 2023-08-30
Enrollment: 280

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.